An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)
ConditionThyroid Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorIlsan Cha hospital
About this trial
This observational study aimed to evaluate the safety and efficacy of postoperative management in patients with thyroid cancer who received subtotal or total thyroidectomy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
19 years of age or older
Those who have been confirmed to have a malignant tumor of the thyroid gland by biopsy or imaging
Subjects who have undergone partial thyroidectomy or total resection within 1 month
Those who have agreed to the implementation of Chinese medicine treatment
Disqualifiers
○ When it is judged that other diseases other than cancer (dementia, cerebrovascular disease, severe organ failure, etc.) may have a significant effect on the decline of physical function
When it is judged that the life expectancy is less than 3 months and sufficient follow-up cannot be carried out
When emergency or major surgery or surgical intervention is required that takes precedence over postoperative treatment
Pregnant and lactating women
Trial population
Patients who have been diagnosed with thyroid cancer (KCD C73) according to the ICD-10 International Classification of Diseases and have been recommended for postoperative management treatment by a physician or acupuncturist
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
THYCA-QoL score at the time of discharge (1w) of hospitalization performed for postoperative management purposes
The THYCA-QoL is a health-related quality of life questionnaire developed for thyroid cancer and thyroid cancer survivors using methodologically proven standard guidelines and validated questionnaires to improve symptoms, treatment, follow-up and disease experience in thyThe THYCA-QoL is a health-related quality of life questionnaire developed for thyroid cancer and thyroid cancer survivors using methodologically proven standard guidelines and validated questionnaires to improve symptoms, treatment, follow-up and disease experience in thyroid cancer survivors. roid cancer survivors.
Time frame
At the end of week 1(each cycle is 7days)Secondary outcomes
1
Change in THYCA-QoL over time series
The THYCA-QoL is a health-related quality of life questionnaire developed for thyroid cancer and thyroid cancer survivors using methodologically proven standard guidelines and validated questionnaires to improve symptoms, treatment, follow-up and disease experience in thyThe THYCA-QoL is a health-related quality of life questionnaire developed for thyroid cancer and thyroid cancer survivors using methodologically proven standard guidelines and validated questionnaires to improve symptoms, treatment, follow-up and disease experience in thyroid cancer survivors. roid cancer survivors.
Time frame
At the end of Day 1, week 1, week 2, 1 month, 2 month, 3 month, 4 month, 6 month, 12 month2
EORTC-QLQ-C30
It is a health-related questionnaire for cancer patients. It consists of 3 subdomains: overall quality of life, functional area, and symptom domain, a total of 30 items.
Time frame
At the end of Day 1, week 1, week 2, 1 month, 2 month, 3 month, 4 month, 6 month, 12 month3
BCQ
It is a dialectic tool that divides the physiological and pathological conditions and symptoms of the human body into three dialectics: concession, yinhe, and word-body, and identifies the deteriorated condition of the human body.
Time frame
At the end of Day 1, week 1, week 24
CHPIQ
It is a key diagnostic technology that plays a decisive role in the selection of prescriptions in traditional Chinese medicine, and it is a symptom-based cold and heat pattern identification questionnaire that has been recognized for its reliability and validity. CHPIQ).
Time frame
At the end of Day 1, week 1, week 2Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ilsan Cha hospital
Lead sponsor
CHA University
Sponsor institution
Source ClinicalTrials.gov